Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Endocrinology
•
HIV & AIDS
•
Primary Care
What patient-specific factors would influence your decision to initiate semaglutide therapy in patients with HIV-associated lipohypertrophy?
Answer from: at Academic Institution
I would consider it if the patient had diabetes. But there is not much data on this question.
Comments
at George Washington School Of Medicine
Is there any data?
13807
Sign in or Register to read more
25057
Related Questions
What is your approach to a positive PPD or IGRA in a patient with well-controlled HIV without significant TB risk factors?
What steps do you recommend to ensure continued viral suppression and prevent drug resistance in an HIV patient on injectable cabotegravir and rilpivirine who misses their scheduled injection appointment by two weeks?
How do you use CD4% in clinical practice in management of patients living with HIV?
How do you approach management for patient's with HIV on ART with persistent low level viremia but no new resistance mutations identified?
Would you consider using long-acting injectable cabotegravir/rilpivirine for pregnant women with HIV?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Do you routinely prescribe GLP-1 receptor agonists to people living with HIV (PLH) with obesity?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
Do you recommend stopping a SGLT2i indefinitely if a patient with chronic kidney disease and diabetes develops euglycemic diabetic ketoacidosis?
During treatment of severe osteoporosis, with PTH analogs (abaloparatide or) would rise in alkaline phosphatase level > 200 (in setting of normal GGT) warrant discontinuation of medication?
Is there any data?